Market Cap

Zhongzhi Pharmaceutical Holdings Ltd Market Capitalization:

HK$1.20 Billion

HKD as of July 1, 2024

US$154.2 Million

business Zhongzhi Pharmaceutical Holdings Ltd Company Profile

Zhongzhi Pharmaceutical Holdings Ltd Main Stock Listing

HKEX: 3737

Market Capitalization History of Zhongzhi Pharmaceutical Holdings Ltd

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Drug Manufacturers—Specialty & Generic
Company Market Cap (USD)
Zoetis Inc. $80.13 B
MERCK Kommanditgesellschaft auf Aktien $71.24 B
Takeda Pharmaceutical Company Limited $41.23 B
Haleon plc $37.32 B
Teva Pharmaceutical Industries Limited $18.88 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $808.65 B
Novo Nordisk $622.07 B
UnitedHealth Group $450.89 B
Johnson & Johnson $350.63 B
Merck $318.75 B

Yearly evolution of Zhongzhi Pharmaceutical Holdings Ltd market cap

Date Market Cap YoY Change
Jan. 1, 2024 HK$1.19 B 20.00%
Jan. 1, 2023 HK$993.1 M 18.75%
Jan. 1, 2022 HK$836.3 M -40.37%
Jan. 1, 2021 HK$1.40 B 25.78%
Jan. 1, 2020 HK$1.12 B -15.23%
Jan. 1, 2019 HK$1.32 B -15.17%
Jan. 1, 2018 HK$1.55 B 4.71%
Jan. 1, 2017 HK$1.48 B -19.05%
Jan. 1, 2016 HK$1.83 B

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +265.99%

$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

Zhongzhi Pharmaceutical Holdings Ltd Categories

China languages Healthcare languages Drug Manufacturers—Specialty & Generic
China Healthcare China Drug Manufacturers—Specialty & Generic

Stocks & Indices

Zhongzhi Pharmaceutical Holdings Ltd has the following listings and related stock indices.


Stock: HKEX: 3737

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.